BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6153260)

  • 1. Zoster immune globulin prophylaxis of disseminated zoster in compromised hosts. A randomized trial.
    Stevens DA; Merigan TC
    Arch Intern Med; 1980 Jan; 140(1):52-4. PubMed ID: 6153260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Reactivation of herpes zoster infection by varicella-zoster virus].
    Cvjetković D; Jovanović J; Hrnjaković-Cvjetković I; Brkić S; Bogdanović M
    Med Pregl; 1999; 52(3-5):125-8. PubMed ID: 10518396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acyclovir and specific anti-varicella-herpes zoster immunoglobulins in the treatment of varicella-zoster virus infection in 113 adults].
    Senneville E; Chidiac C; Brouillard M; Beuscart C; Leroy O; Sivery B; Beaucaire G; Mouton Y
    Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):568-71. PubMed ID: 2166935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum antibody levels as risk factors in the dissemination of herpes zoster.
    Mazur MH; Whitley RJ; Dolin R
    Arch Intern Med; 1979 Dec; 139(12):1341-5. PubMed ID: 229783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of zoster immune plasma. Treatment of cutaneous disseminated zoster in immunocompromised patients.
    Groth KE; McCullough J; Marker SC; Howard RJ; Simmons RL; Najarian JS; Balfour HH
    JAMA; 1978 May; 239(18):1877-9. PubMed ID: 205687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zoster immune globulin.
    Spitler LE
    Arch Intern Med; 1980 Jan; 140(1):28-9. PubMed ID: 6243457
    [No Abstract]   [Full Text] [Related]  

  • 7. [Specific immunoglobulin and acyclovir in the prevention and treatment of varicella zoster infections in children with neoplastic diseases].
    Lakomek M; Tillmann W; Schrewe H; Prindull G
    Klin Padiatr; 1986; 198(3):281-4. PubMed ID: 3723992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Passive immunotherapy in herpes zoster. A pilot study with intravenous hyperimmune globulin].
    Kaufmann R
    Z Hautkr; 1985 Jan; 60(1-2):204, 207-10. PubMed ID: 3984430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel vaccine (Zostavax) to prevent herpes zoster and postherpetic neuralgia.
    Holcomb K; Weinberg JM
    J Drugs Dermatol; 2006 Oct; 5(9):863-6. PubMed ID: 17039651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-zoster virus infections in pregnancy.
    Fox GN; Strangarity JW
    Am Fam Physician; 1989 Feb; 39(2):89-98. PubMed ID: 2537001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of varicella by zoster immune globulin.
    Brunell PA; Ross A; Miller LH; Kuo B
    N Engl J Med; 1969 May; 280(22):1191-4. PubMed ID: 4181206
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.
    Zaia JA; Levin MJ; Preblud SR; Leszczynski J; Wright GG; Ellis RJ; Curtis AC; Valerio MA; LeGore J
    J Infect Dis; 1983 Apr; 147(4):737-43. PubMed ID: 6341478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind study comparing 2 dosages of valacyclovir hydrochloride for the treatment of uncomplicated herpes zoster in immunocompromised patients 18 years of age and older.
    Arora A; Mendoza N; Brantley J; Yates B; Dix L; Tyring S
    J Infect Dis; 2008 May; 197(9):1289-95. PubMed ID: 18422441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preventive and therapeutic effect convalescent zona and varicella sera in high risk children (659 cases)].
    Gaiffe M; Herzog F; Schweisguth O
    Nouv Presse Med; 1976 May; 5(20):1285-8. PubMed ID: 59342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study tests Varicella-Zoster vaccine for over 60-years-old persons. Protection from Herpes zoster and postherpetic neuralgia].
    MMW Fortschr Med; 2006; Spec no.1():14-5. PubMed ID: 16872127
    [No Abstract]   [Full Text] [Related]  

  • 18. Testing the properties of an experimental batch of zoster immune gammaglobulin (ZIG).
    Trlifajová J; Petera A; Ryba M; Pokorný J
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(1):42-50. PubMed ID: 93127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster immune globulin (human) (VARIZIG) in immunocompromised patients: a subgroup analysis for safety and outcomes from a large, expanded-access program.
    Gans H; Chemaly RF
    BMC Infect Dis; 2021 Jan; 21(1):46. PubMed ID: 33430796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
    Geiser CF; Bishop Y; Myers M; Jaffe N; Yankee R
    Cancer; 1975 Apr; 35(4):1027-30. PubMed ID: 46775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.